New Blood for Big Pharma

A specialized MBA program at Rutgers aims to produce skilled managers for the volatile pharmaceutical industry

New Jersey is home to some of the world's leading pharmaceutical companies, as well as Rutgers University. That's why in 1999, when pharma industry insiders were seeking educators to train MBAs specialized in pharmaceutical operations, they turned to their home state's best-known institution.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.